The Institute of Human Virology, Nigeria (IHVN) is expanding its research focus to include sickle cell disease and cancer, in addition to its ongoing work on infectious diseases such as HIV, TB, and malaria, to improve care for Nigerians.
The Chief Executive Officer (CEO) of IHVN, Dr. Patrick Dakum, while interacting with journalists at the sidelines of the International Research Centre of Excellence’s (IRCE) 2nd Annual Scientific Symposium in Abuja, noted that by working together and sharing experiences, better health outcomes for Nigerians can be achieved.
The symposium, themed Expanding Partnerships to Sickle Cell Disease and Cancer Research, aims to ensure health research benefits the citizens of Nigeria.
He said, “Our goal is to ensure that every individual has access to quality healthcare services, regardless of their location or socio-economic status.”
Dr. Dakum emphasised the need for sustainable solutions, citing the challenges of funding and the rapid turnover of healthcare workers.
“We cannot rely solely on external funding or expertise. We must develop our own capacity and ensure that our solutions are sustainable in the long term.”
“IHVN is already making strides in this direction with its work on sickle cell disease and cancer screening. By leveraging existing structures and resources, the institute aims to expand access to these services across the country.”
“We are not starting from scratch. We are building on the experience and expertise we have gained in HIV/AIDS and TB control.
“We are also collaborating with international partners, such as the University of Maryland, to exchange knowledge and best practices.”
The CEO also highlighted the importance of mentorship and capacity building. “We need to ensure that our healthcare workers are equipped with the necessary skills and knowledge to provide quality services. We must also mentor the next generation of healthcare professionals to ensure continuity of care.”
“As Nigeria continues to grapple with various health challenges, the IHVN’s approach offers a beacon of hope.”
“By prioritising collaboration, sustainability, and capacity building, the institute is helping to pave the way for a healthier future for all Nigerians.”
“We are committed to making a difference in the lives of Nigerians. We will continue to work tirelessly to ensure that our healthcare system is safe, effective, and accessible to all.” He stated.
Similarly, the Executive Director of the International Research Centre of Excellence (IRCE), Professor Alash’le Abimiku, explained that the expansion of research into sickle cell disease and cancer is a critical step towards addressing the significant burden of non-communicable diseases in Nigeria.
Abimiku noted that the centre is committed to supporting this effort through cutting-edge research and collaboration with international partners.
Abimiku also emphasised the importance of research in improving healthcare outcomes, saying, “We must invest in research to understand the unique challenges of these diseases in our population and develop effective solutions.
“Our goal is to translate research findings into practical applications that benefit patients and communities.”
On the impact of sickle cell disease, Abimiku noted, “Sickle cell disease is a major public health concern in Nigeria, affecting millions of lives.
“We must prioritise research and education to reduce the stigma and improve management of this disease.”
Regarding cancer, Abimiku stated, “Cancer is a growing threat in Nigeria, and we must act now to improve diagnosis, treatment, and care. Our research will focus on identifying effective strategies to address this burden.”
On the partnership between IHVN and IRCE, Professor Abimiku said, “We are proud to collaborate with IHVN on this critical research agenda. Together, we can make a meaningful difference in the lives of Nigerians affected by these diseases.”
“Our ultimate goal is to improve healthcare outcomes and save lives. We are committed to working tirelessly to achieve this vision,” she said.
Meanwhile, Prof. Taofeek Owonikoko, in his keynote address, urged the government to develop a national plan and policy to address the growing burden of cancer in Nigeria.
According to Prof. Owonikoko, “We need a multi-faceted approach to tackle cancer in Nigeria. This includes improving awareness, increasing access to screening and treatment, and investing in research to develop effective solutions. We cannot afford to wait; we must act now to address this growing health crisis.”
Prof. Owonikoko emphasised the importance of a collaborative approach, saying, “We must work together—researchers, policymakers, healthcare professionals, and patients—to develop a comprehensive plan to address cancer in Nigeria.
“We owe it to ourselves, our children, and future generations to take action against this devastating disease,” he said.
The call to action comes as Nigeria grapples with a growing cancer burden, highlighting the need for a coordinated national response to address this critical health issue.
ALSO READ THESE TOP STORIES FROM NIGERIAN TRIBUNE
